Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, September 1998, p. 617-621, Vol. 5, No. 5
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Analysis of Immunoglobulin A Antibodies to
Helicobacter pylori in Serum and Gastric Juice in Relation
to Mucosal Inflammation
Shunji
Hayashi,1,*
Toshiro
Sugiyama,2
Kenji
Yokota,3
Hiroshi
Isogai,4
Emiko
Isogai,5
Keiji
Oguma,3
Masahiro
Asaka,2
Nobuhiro
Fujii,6 and
Yoshikazu
Hirai1
Department of Microbiology, Jichi Medical
School, Tochigi-ken 329-0498,1
Third
Department of Internal Medicine, Hokkaido University School of
Medicine, Sapporo 060-8638,2
Department
of Bacteriology, Okayama University Medical School, Okayama
700-8558,3
Animal Experimentation
Center4 and
Department of
Microbiology,6 Sapporo Medical University School
of Medicine, Sapporo 060-8556, and
Department of Hygiene,
Health Sciences University of Hokkaido, Hokkaido
061-0293,5 Japan
Received 29 December 1997/Returned for modification 24 March
1998/Accepted 12 June 1998
 |
ABSTRACT |
Helicobacter pylori is a major etiologic agent in
gastroduodenal disorders. In this study, immunoglobulin A (IgA)
antibodies to H. pylori antigens were evaluated in serum
and gastric juice specimens obtained from patients with gastritis or
peptic ulcers by utilizing antibody capture enzyme-linked immunosorbent
assays (ACELISAs). Urease
subunit (UA), urease
subunit (UB),
the 66-kDa heat shock protein (HSP), and the 25-kDa protein (25K) were
used as antigens for the ACELISAs. The antibody titers of the ACELISAs
reflect the ratio of H. pylori-specific IgA to total IgA.
The ratio is stable, although the antibody concentration fluctuates in
gastric juice. By using ACELISAs it was possible to evaluate
quantitatively not only serum IgA antibodies but also gastric juice
secretory IgA (S-IgA) antibodies. In both serum IgA and gastric juice
S-IgA ACELISAs, the titers of antibody to HSP and 25K were remarkably
correlated with the histologic grade of gastritis, whereas those to UA
and UB were not strongly correlated with histologic grade. Thus, it is
useful for estimating the histologic grade of gastritis to quantify
serum IgA and gastric juice S-IgA antibodies to HSP and 25K.
 |
INTRODUCTION |
Helicobacter pylori is a
causative agent in chronic gastritis (31), peptic ulcers
(9), and gastric cancer (7). The detection of
antibodies specific to H. pylori in serum is important in the diagnosis of these diseases (5, 24).
However, H. pylori infections occur in the gastric
mucosa (29). The mucosal immune response against H. pylori plays an important role in the development of gastric
mucosal lesions (1, 20, 25, 26). Immunoglobulin A (IgA)
is the main immunoglobulin in secretions (30). Thus, it is thought to be important to detect gastric juice secretory IgA
(S-IgA) antibodies to H. pylori. It is, however, difficult to evaluate quantitatively S-IgA antibodies in gastric juice, because the concentration of S-IgA fluctuates greatly in gastric juice.
To solve this problem, we have developed antibody capture enzyme-linked
immunosorbent assays (ACELISAs) (10), which are used to
assay serum IgA and gastric juice S-IgA antibodies specific to H. pylori. Urease
subunit (UA), urease
subunit (UB), the 66-kDa heat shock protein (HSP), and the 25-kDa protein (25K) were
obtained from H. pylori and used as antigens for the
ACELISAs (33). These are the major proteins which are
recognized by the sera as well as the gastric juice of H. pylori-positive patients (24). In this report, we
discuss the relationships between IgA antibodies to these H. pylori antigens and gastric mucosal inflammation.
 |
MATERIALS AND METHODS |
Sera and gastric juice.
Serum and gastric juice samples were
obtained from 19 H. pylori-positive patients for this study.
The ages of the patients ranged between 20 and 80 years, and there were
16 males and 3 females. Eleven patients had chronic gastritis, and
eight had peptic ulcers. All of the patients were diagnosed through
endoscopic examinations. Serum and gastric juice samples were also
collected from six H. pylori-negative healthy male
volunteers. The age of the volunteers ranged between 19 and 29 years.
The volunteers were used as a negative-control group. Serum samples
were stored at
80°C until tested. Gastric juice samples were
acquired by washing gastric mucosa with phosphate-buffered saline (PBS)
(pH 7.4). The washings were neutralized and dialyzed with distilled water (32). After dialysis, the samples were lyophilized and stored at
20°C until tested.
Gastric biopsy specimens.
Biopsies were performed by
utilizing endoscopy from both the disease and the control groups. Three
biopsy specimens were taken from the gastric antrum of each subject.
One antral biopsy specimen was used for culture, and another was used
for a rapid urease test (Minitek Disk; BBL, Cockeysville, Md.)
(14). The third specimen was fixed with formalin for
histopathology, and immunostaining was performed by using anti-H.
pylori monoclonal antibody (24). H. pylori
infection was judged positive when the result of either the culture
test, the rapid urease test, or the immunostaining was positive.
The biopsy tissue sections were also stained with hematoxylin and
eosin, and the numbers of infiltrated cells were counted per 0.015 mm2. Three sections from antral biopsy tissue were examined
for each H. pylori-positive patient, and the median value of
the three examinations was considered the histologic grade of gastritis (1).
H. pylori antigens.
H. pylori (ATCC 43504)
was inoculated onto brain heart infusion agar (Difco, Detroit, Mich.)
containing 8% horse blood and incubated microaerobically (GasPak
System without catalyst; BBL) at 37°C for 5 days (12). The
organisms were harvested, washed three times with PBS, and resuspended
in electrophoresis sample buffer (10 mM Tris-HCl [pH 6.8] containing
1% sodium dodecyl sulfate, 1% 2-mercaptoethanol, 10% glycerol, and 1 mM phenylmethylsulfonyl fluoride). The resulting suspension was
sonicated and heated at 100°C for 5 min. Samples were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a
12.5% separating gel and a 5% stacking gel. After electrophoresis,
the 66-kDa, 60-kDa, 30-kDa, and 25-kDa proteins were cut out and
electroeluted from the separating gel. The solution containing each
antigen was dialyzed against 0.1 M NaHCO3 (pH 8.4). After
dialysis, the protein concentrations of these antigen solutions were
assayed by using the Bio-Rad protein assay kit (Bio-Rad, Richmond,
Calif.) and adjusted to 100 µg/ml each. Subsequently, 2 ml of each
antigen solution was mixed with 120 µl of
N-hydroxysuccinimide biotin (1 mg/ml) in dimethyl sulfoxide, kept at room temperature for 4 h, and dialyzed against PBS
(17). After dialysis, the protein concentrations of these
antigen solutions were assayed again and adjusted to 10 µg/ml each,
and the solutions were stored at
80°C until tested.
The 30- and 60-kDa proteins were identified as UA and UB, respectively,
by N-terminal amino acid analysis. The 66-kDa protein was identified as
HSP in the same way (33). However, 25K could not be
identified. The N-terminal 20 amino acids of 25K were similar (55%
homology) to those of H. pylori ferritin with a molecular mass of 19.3 kDa (8, 27). On the other hand, H. pylori has a 25-kDa outer membrane protein which binds to laminin
(28). Thus, either the ferritin or the laminin-binding
protein may be 25K.
Serum IgA ACELISA.
Flat-bottom 96-well microtiter plates
(EIA Plate High Binding; Costar, Cambridge, Mass.) were coated with 100 µl of goat anti-human IgA (lot H075, monospecific for the
chain;
BioMakor, Rehovot, Israel), diluted 1:100 in 50 mM
carbonate-bicarbonate buffer (pH 9.6), per well. After an overnight
incubation at 4°C, the plates were washed three times with PBS
containing 0.1% Tween 20. The free binding sites were blocked by
adding 150 µl of PBS containing 1% bovine serum albumin (PBS-BSA)
and incubating for 1 h at 37°C. The plates were then washed, and
100 µl of test serum diluted 1:100 in PBS-BSA was added to each well
and incubated for 2 h at 37°C, after which a fixed amount of IgA
was captured per well. Under this condition, 126 ng of IgA (mean,
126.0 ± 1.1 ng; range, 123.8 to 128.1 ng) was consistently
captured per well (10). The plates were then washed, and 100 µl of each biotinylated H. pylori antigen diluted 1:100 in
PBS-BSA was added to each well and incubated for 2 h at 37°C.
After a wash, 100 µl of alkaline phosphatase-conjugated streptavidin
(Sumitomo Kinzoku Co., Tokyo, Japan) diluted 1:2,000 in PBS was added
and incubated for 1 h at 37°C. After a wash, 50 µl of the
substrate solution of an ELISA amplification system (Gibco BRL,
Gaithersburg, Md.) (22, 23) was added and incubated at room
temperature for 15 min, and 50 µl of an amplifier solution was added
and incubated at room temperature for 15 min. The reaction was
terminated by adding 50 µl of 0.3 M H2SO4.
The optical density (OD) of the reaction was measured at 495 nm with a
microplate reader (model 3550 EIA reader; Bio-Rad).
The OD represents the quantity of each H. pylori
antigen-specific IgA per well. Thus, the OD corresponds to the quantity
of H. pylori antigen-specific IgA contained in 126 ng of
IgA. The amount of H. pylori antigen-specific IgA contained
in 100 ng of IgA was considered the antibody titer.
Gastric juice S-IgA ACELISA.
Microtiter plates were coated
with 100 µl of goat anti-human secretory component (lot H211,
monospecific for secretory component; BioMakor), diluted 1:1,000 in 50 mM carbonate-bicarbonate buffer (pH 9.6), per well and incubated
overnight at 4°C. After the wells were washed, they were blocked with
PBS-BSA. After a wash, 100 µg of lyophilized test gastric juice was
dissolved in 100 µl of PBS-BSA, added to each well, and incubated for
2 h at 37°C, after which a fixed amount of S-IgA was captured
per well. Under this condition, 39 ng of S-IgA (mean, 39.0 ± 0.6 ng; range, 37.5 to 40.2 ng) was consistently captured per well
(10). The plates were consecutively treated with each
biotinylated H. pylori antigen and alkaline
phosphatase-conjugated streptavidin. Substrate, amplifier, and stop
solutions were added consecutively, and the OD was then measured as
mentioned above.
The OD corresponds to the quantity of each H. pylori
antigen-specific S-IgA in 39 ng of S-IgA. The amount of H. pylori antigen-specific S-IgA contained in 100 ng of S-IgA was
defined as the antibody titer.
Statistical analysis.
The difference between patients and
negative controls was evaluated by an unpaired Student's t
test. The correlation between antibody titer and histologic grade was
evaluated by Spearman's rank correlation. A two-tailed P
value of <0.05 was considered statistically significant.
 |
RESULTS |
IgA and S-IgA ACELISAs.
The results from the IgA and S-IgA
ACELISAs are shown in Fig. 1. With all
antigens, the H. pylori-positive patients had significantly higher serum IgA antibody titers than the H. pylori-negative
controls. The titers of gastric juice S-IgA antibody to any H. pylori antigens were also significantly higher in the patients
than in the control group.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Antibody titers to H. pylori antigens (25K,
HSP, UA, and UB) measured by IgA and S-IgA ACELISAs. , H. pylori-positive patients; , H. pylori-negative
healthy volunteers. Horizontal bars, medians.
|
|
Correlation between serum IgA and histologic grade.
The
histologic grade of gastritis was determined according to the number of
infiltrated cells per 0.015 mm2 obtained from the gastric
biopsy. The results are summarized in Fig.
2. With all antigens, IgA antibody titers
were positively correlated with histologic grade. The correlation
between anti-25K and anti-HSP IgA antibody titer and histologic grade
was especially significant. On the other hand, the correlation between
anti-UA and anti-UB IgA antibody titer and histologic grade was
statistically significant but not remarkable.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Correlation between serum IgA antibody titers and
histologic grade of gastritis in patients. , H. pylori-positive patients with chronic gastritis; ,
H. pylori-positive patients with peptic ulcers.
|
|
Correlation between gastric juice S-IgA and histologic grade.
The anti-UA and UB S-IgA antibody titers were negatively correlated
with the histologic grade of gastritis (Fig.
3); however, the correlation was not
remarkable. On the other hand, S-IgA antibody titers to 25K and HSP
were positively correlated with histologic grade (Fig. 3).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Correlation between gastric juice S-IgA antibody titers
and histologic grade of gastritis in patients. , H. pylori-positive patients with chronic gastritis; ,
H. pylori-positive patients with peptic ulcers.
|
|
 |
DISCUSSION |
In general, the antibody titer indicates the concentration of
antibody. This is strongly influenced by the concentration of total
immunoglobulin. However, the antibody titer in the ACELISA does not
reflect the concentration of antibody but, rather, the ratio of
H. pylori-specific IgA to total IgA (4, 10).
The ratio is negligibly influenced by the concentration of total IgA. Thus, the S-IgA ACELISA made it possible to evaluate quantitatively S-IgA antibodies to H. pylori antigens in gastric
juice, even though the concentration of total S-IgA in gastric juice
fluctuates greatly. The S-IgA ACELISA does not measure serum IgA which
leaks into gastric juice, because it uses anti-secretory component. The
S-IgA ACELISA may measure not only S-IgA but S-IgM associated with
secretory component. However, the concentration of S-IgM in secretions
is far less than that of S-IgA (2, 3, 21). We tried to
measure the concentration of S-IgM in gastric juice but did not detect
it (unpublished data). Thus, S-IgM would have little influence on the
results of S-IgA ACELISA. On the other hand, the IgA ACELISA was well
suited for detecting H. pylori-specific IgA in serum.
In both ACELISAs, the antibody titers of the patients were
significantly higher than those of the controls. Both are useful in the
diagnosis of H. pylori-associated diseases.
Furthermore, in this type of ELISA, false-positive results are rarely
obtained, though highly positive sera occasionally give relatively low
values (11).
In H. pylori-positive patients, the serum IgA antibody
titers to each H. pylori antigen were positively
correlated with the histologic grade of gastritis. The correlation was
especially significant between anti-25K and anti-HSP serum IgA antibody
titers and histologic grade. The titers of gastric juice S-IgA antibody to 25K and HSP were also positively correlated with histologic grade.
These results suggest that IgA and S-IgA antibodies to 25K and HSP are
closely associated with the histologic grade of gastritis. Thus, it is
beneficial for evaluating the histologic grade of gastritis to quantify
serum IgA and gastric juice S-IgA antibodies to 25K and HSP. On the
other hand, titers of gastric juice S-IgA antibody to UA and UB were
negatively correlated with histologic grade, though the correlation was
not remarkable. The pathophysiological states of anti-UA and -UB S-IgA
may be different from those of anti-25K and -HSP S-IgA.
Urease is an essential enzyme for H. pylori
colonization (18). The gastric juice S-IgA antibodies to
urease, induced by oral immunization, can prevent
Helicobacter infections in animal models (6, 13, 15,
19). However, serum IgG antibodies, induced by intravenous or
subcutaneous immunization, cannot (13, 16). Thus, gastric
juice S-IgA antibodies would play an important role in H. pylori infection. Our studies demonstrated that human serum IgA
antibodies to urease were positively correlated with the histologic
grade of gastritis. On the contrary, gastric juice S-IgA antibodies to
urease were negatively correlated with histologic grade, though the
correlation was not remarkable. These results suggest that the S-IgA
antibodies to urease may bind to H. pylori in gastric
mucosa and inhibit H. pylori colonization in humans as
well as animal models.
 |
ACKNOWLEDGMENTS |
This study was supported in part by a Grant-in-Aid for Scientific
Research (no. 09770188) from the Japanese Ministry of Education, Science, Sports and Culture; a grant (no. 8-14) from the Japanese Ministry of Health and Welfare; and a grant from the Nakano Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Jichi Medical School, 3311-1 Yakushiji,
Minamikawachi-machi, Tochigi-ken 329-0498, Japan. Phone:
81-285-58-7332. Fax: 81-285-44-1175. E-mail:
shunhaya{at}jichi.ac.jp.
 |
REFERENCES |
| 1.
|
Ando, T.,
K. Kusugami,
M. Ohsuga,
M. Shinoda,
M. Sakakibara,
H. Saito,
A. Fukatsu,
S. Ichiyama, and M. Ohta.
1996.
Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis.
Am. J. Gastroenterol.
91:1150-1156[Medline].
|
| 2.
|
Biewenga, J.,
A. E. Stoop,
H. A. M. D. van der Heijden,
S. van der Baan, and G. J. van Kamp.
1995.
Albumin and immunoglobulin levels in nasal secretions of patients with nasal polyps treated with endoscopic sinus surgery and topical corticosteroids.
J. Allergy Clin. Immunol.
96:334-340[Medline].
|
| 3.
|
Bresson-Hadni, S.,
M. Rossel,
E. Seilles,
D. A. Vuitton,
K. Guennoune,
B. Hory,
J. P. Miguet,
M. Gillet,
C. Vincent, and J. P. Revillard.
1991.
Serum and bile secretory immunoglobulins and secretory component during the early postoperative course after liver transplantation.
Hepatology
14:1046-1053[Medline].
|
| 4.
|
Burke, D. S.,
A. Nisalak, and M. A. Ussery.
1982.
Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid.
J. Clin. Microbiol.
16:1034-1042[Abstract/Free Full Text].
|
| 5.
| Czinn, S. J., H. S. Carr, and W. T. Speck. 1991. Diagnosis of gastritis caused by Helicobacter
pylori in children by means of an ELISA. Rev. Infect. Dis.
13(Suppl. 8):S700-S703.
|
| 6.
|
Czinn, S. J.,
A. Cai, and J. G. Nedrud.
1993.
Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization.
Vaccine
11:637-642[Medline].
|
| 7.
|
Forman, D., and the Eurogast Study Group.
1993.
An international association between Helicobacter pylori infection and gastric cancer.
Lancet
341:1359-1362[Medline].
|
| 8.
|
Frazier, B. A.,
J. D. Pfeifer,
D. G. Russell,
P. Falk,
A. N. Olsén,
M. Hammar,
T. U. Westblom, and S. J. Normark.
1993.
Paracrystalline inclusions of a novel ferritin containing nonheme iron, produced by the human gastric pathogen Helicobacter pylori: evidence for a third class of ferritins.
J. Bacteriol.
175:966-972[Abstract/Free Full Text].
|
| 9.
|
Graham, D. Y.
1991.
Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease.
J. Gastroenterol. Hepatol.
6:105-113[Medline].
|
| 10.
|
Hayashi, S.,
T. Sugiyama,
K. Hisano,
T. Awakawa,
I. Kurokawa,
A. Yachi,
H. Isogai,
E. Isogai,
K. Yokota,
Y. Hirai,
K. Oguma, and N. Fujii.
1996.
Quantitative detection of secretory immunoglobulin A to Helicobacter pylori in gastric juice: antibody capture enzyme-linked immunosorbent assay.
J. Clin. Lab. Anal.
10:74-77[Medline].
|
| 11.
|
Hodgson, J., and P. Morgan-Capner.
1984.
Evaluation of a commercial antibody capture enzyme immunoassay for the detection of rubella specific IgM.
J. Clin. Pathol.
37:573-577[Abstract/Free Full Text].
|
| 12.
|
Itoh, T.,
Y. Yanagawa,
M. Shingaki,
M. Takahashi,
A. Kai,
M. Ohashi, and G. Hamana.
1987.
Isolation of Campylobacter pyloridis from human gastric mucosa and characterization of the isolates.
Microbiol. Immunol.
31:603-614[Medline].
|
| 13.
|
Lee, C. K.,
R. Weltzin,
W. D. Thomas, Jr.,
H. Kleanthous,
T. H. Ermak,
G. Soman,
J. E. Hill,
S. K. Ackerman, and T. P. Monath.
1995.
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
J. Infect. Dis.
172:161-172[Medline].
|
| 14.
|
McNulty, C. A. M., and R. Wise.
1985.
Rapid diagnosis of Campylobacter-associated gastritis.
Lancet
i:1443-1444.
|
| 15.
|
Michetti, P.,
I. Corthesy-Theulaz,
C. Davin,
R. Haas,
A. C. Vaney,
M. Heitz,
J. Bille,
J. P. Kraehenbuhl,
E. Saraga, and A. L. Blum.
1994.
Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.
Gastroenterology
107:1002-1011[Medline].
|
| 16.
|
Negrini, R.,
L. Lisato,
I. Zanella,
L. Cavazzini,
S. Gullini,
V. Villanacci,
C. Poiesi,
A. Albertini, and S. Ghielmi.
1991.
Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa.
Gastroenterology
101:437-445[Medline].
|
| 17.
|
Nerurkar, L. S.,
M. Namba,
G. Brashears,
A. J. Jacob,
Y. J. Lee, and J. L. Sever.
1984.
Rapid detection of herpes simplex virus in clinical specimens by use of a capture biotin-streptavidin enzyme-linked immunosorbent assay.
J. Clin. Microbiol.
20:109-114[Abstract/Free Full Text].
|
| 18.
|
Owen, R. J.,
S. R. Martin, and P. Borman.
1985.
Rapid urea hydrolysis by gastric Campylobacters.
Lancet
i:111.
|
| 19.
|
Pappo, J.,
W. D. Thomas, Jr.,
Z. Kabok,
N. S. Taylor,
J. C. Murphy, and J. G. Fox.
1995.
Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis.
Infect. Immun.
63:1246-1252[Abstract].
|
| 20.
|
Pérez-Pérez, G. I.,
W. R. Brown,
T. I. Cover,
B. E. Dunn,
P. Cao, and M. J. Blaser.
1994.
Correlation between serological and mucosal inflammatory responses to Helicobacter pylori.
Clin. Diagn. Lab. Immunol.
1:325-329[Abstract/Free Full Text].
|
| 21.
|
Prigent-Delecourt, L.,
B. Coffin,
J. F. Colombel,
J. P. Dehennin,
J. P. Vaerman, and J. C. Rambaud.
1995.
Secretion of immunoglobulins and plasma proteins from the colonic mucosa: an in vivo study in man.
Clin. Exp. Immunol.
99:221-225[Medline].
|
| 22.
|
Self, C. H.
1985.
Enzyme amplification a general method applied to provide an immunoassisted assay for placental alkaline phosphatase.
J. Immunol. Methods
76:389-393[Medline].
|
| 23.
|
Stanley, C. J.,
A. Johannsson, and C. H. Self.
1985.
Enzyme amplification can enhance both the speed and the sensitivity of immunoassays.
J. Immunol. Methods
83:89-95[Medline].
|
| 24.
|
Sugiyama, T.,
K. Imai,
H. Yoshida,
Y. Takayama,
T. Yabana,
K. Yokota,
K. Oguma, and A. Yachi.
1991.
A novel enzyme immunoassay for serodiagnosis of Helicobacter pylori infection.
Gastroenterology
101:77-83[Medline].
|
| 25.
| Sugiyama, T., T. Awakawa, S. Hayashi, K. Hisano, T. Yabana, I. Kurokawa, and A. Yachi. 1994. The effect of the immune
response to Helicobacter pylori in the development of
intestinal metaplasia. Eur. J. Gastroenterol. Hepatol.
6(Suppl. 1):S89-S92.
|
| 26.
| Sugiyama, T., T. Yabana, and A. Yachi. 1995. Mucosal immune response to Helicobacter pylori and cytotoxic
mechanism. Scand. J. Gastroenterol. 30(Suppl.
208):30-32.
|
| 27.
|
Tomb, J. F.,
O. White,
A. R. Kerlavage,
R. A. Clayton,
G. G. Sutton,
R. D. Fleischmann,
K. A. Ketchum,
H. P. Klenk,
S. Gill,
B. A. Dougherty,
K. Nelson,
J. Quackenbush,
L. Zhou,
E. F. Kirkness,
S. Peterson,
B. Loftus,
D. Richardson,
R. Dodson,
H. G. Khalak,
A. Glodek,
K. McKenney,
L. M. Fitzegerald,
N. Lee,
M. D. Adams,
E. K. Hickey,
D. E. Berg,
J. D. Gocayne,
T. R. Utterback,
J. D. Peterson,
J. M. Kelley,
M. D. Cotton,
J. M. Weidman,
C. Fujii,
C. Bowman,
L. Watthey,
E. Wallin,
W. S. Hayes,
M. Borodovsky,
P. D. Karp,
H. O. Smith,
C. M. Fraser, and J. C. Venter.
1997.
The complete genome sequence of the gastric pathogen Helicobacter pylori.
Nature
388:539-547[Medline].
|
| 28.
|
Valkonen, K. H.,
T. Wadström, and A. P. Moran.
1997.
Identification of the N-acetylneuraminyllactose-specific laminin-binding protein of Helicobacter pylori.
Infect. Immun.
65:916-923[Abstract].
|
| 29.
|
Warren, J. R., and B. Marshall.
1983.
Unidentified curved bacilli on gastric epithelium in active chronic gastritis.
Lancet
i:1273-1275.
|
| 30.
|
Williams, R. C., and R. J. Gibbons.
1972.
Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal.
Science
177:697-699[Abstract/Free Full Text].
|
| 31.
|
Wyatt, J. I., and M. F. Dixon.
1988.
Chronic gastritis a pathogenetic approach.
J. Pathol.
154:113-124[Medline].
|
| 32.
|
Yachi, A.,
Y. Akahonai,
T. Suzuki,
T. Abe, and S. Maeda.
1984.
The IgA type parietal cell antibody in gastric juice.
Protides Biol. Fluids Proc. Colloq.
32:57-60.
|
| 33.
|
Yokota, K.,
Y. Hirai,
M. Haque,
S. Hayashi,
H. Isogai,
T. Sugiyama,
E. Nagamachi,
Y. Tsukada,
N. Fujii, and K. Oguma.
1994.
Heat shock protein produced by Helicobacter pylori.
Microbiol. Immunol.
38:403-405[Medline].
|
Clinical and Diagnostic Laboratory Immunology, September 1998, p. 617-621, Vol. 5, No. 5
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lin, S.-N., Ayada, K., Zhao, Y., Yokota, K., Takenaka, R., Okada, H., Kan, R., Hayashi, S., Mizuno, M., Hirai, Y., Fujinami, Y., Oguma, K.
(2005). Helicobacter pylori heat-shock protein 60 induces production of the pro-inflammatory cytokine IL8 in monocytic cells. J Med Microbiol
54: 225-233
[Abstract]
[Full Text]
-
Takenaka, R., Yokota, K., Ayada, K., Mizuno, M., Zhao, Y., Fujinami, Y., Lin, S.-N., Toyokawa, T., Okada, H., Shiratori, Y., Oguma, K.
(2004). Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology
150: 3913-3922
[Abstract]
[Full Text]
-
Yunoki, N., Yokota, K., Mizuno, M., Kawahara, Y., Adachi, M., Okada, H., Hayashi, S., Hirai, Y., Oguma, K., Tsuji, T.
(2000). Antibody to Heat Shock Protein Can Be Used for Early Serological Monitoring of Helicobacter pylori Eradication Treatment. CVI
7: 574-577
[Abstract]
[Full Text]